Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT02132949

Completed

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer (BERENICE)

Breast Cancer
NCT02949167

Active, not recruiting

MyHealth: Follow-up After Breast Cancer Treatment (MyHealth)

Breast Cancer
NCT03919682

Completed

Promoting Early Detection of Breast Cancer in Rural Rwanda: Impact of Community Health Worker and Nurse Training (BCED)

Breast Cancer
NCT02780271

Completed

Diet and Physical Activity Changes Among Latina Breast Cancer Survivors

Breast Cancer
NCT02167854

Completed

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Breast Cancer
NCT04449809

Withdrawn

Exercise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Breast Conservation Therapy for Women With Early Stage Breast Cancer (EXERT-BC)

Breast Cancer
NCT04517305

Completed

Pyrotinib Plus Vinorelbine in HER2+ Metastatic Breast Cancer Patients

Breast Cancer
NCT01823835

Terminated

A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Breast Cancer
NCT00580333

Completed

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Breast Cancer
NCT04817709

Completed

Development of a Patient Decision Aid for Women Considering Breast Reconstruction

Breast Carcinoma
NCT03983395

Terminated

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Breast Cancer
NCT04899128

Active, not recruiting

Treatment With Pyrotinib-Based Therapy in Lapatinib Resistant HER2-Positive Metastatic Breast Cancer

Breast Cancer
NCT03959618

Completed

Intravenous Chemotherapy and Plant-based Dietary Supplements (CIVCAP)

Breast Cancer
NCT02909751

Completed

Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer (NeoToc)

Breast Cancer
NCT02936206

Terminated

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Breast Cancer
NCT02953860

Completed

Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer

Breast Cancer
NCT03983538

Completed

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer
NCT03761420

Completed

Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome

Breast Neoplasm
NCT02266173

Completed

Observational Study of Pertuzumab Safety in Participants With Breast Cancer

Breast Cancer
NCT00004067

Completed

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Breast Cancer
NCT04002570

Completed

Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients (CCB-RT)

Breast Cancer
NCT01127373

Completed

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

Breast Cancer
NCT02855775

Completed

Monoclonal Antibodies Elimination in Breast Cancer Patient (PK-MAB)

Breast Cancer
NCT00677430

Completed

Quantitative Analysis of Outcomes in Breast Reconstruction

Breast Cancer
NCT00365417

Completed

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

Breast Cancer
NCT01857193

Completed

Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer

Breast Cancer
NCT03991260

Completed

99mTc-ADAPT6-based HER2 Imaging in Breast Cancer (99mTc-ADAPT6)

Breast Cancer
NCT03144037

Completed

Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors (ALPA)

Breast Cancer
NCT04818996

Completed

Evaluation of the Effect of Mediterranean Diet on Breast Cancer Patients

Breast Cancer
NCT03097653

Completed

Decision-aid on Breast Cancer Screening

Breast Cancer
NCT03248427

Completed

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. (CORALLEEN)

Breast Cancer
NCT03863301

Withdrawn

MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer (ABLATIVE-2)

Breast Cancer
NCT04281355

Withdrawn

Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy (INDAX)

Breast Cancer
NCT00003654

Terminated

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Breast Cancer
NCT03556397

Completed

Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy

Breast Cancer
NCT02681523

Terminated

ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer. (ALERT)

Breast Cancer
NCT02854618

Unknown

Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus (EVERIMMUN)

Breast Cancer
NCT02137837

Terminated

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

Breast Cancer
NCT01452399

Completed

A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients

Breast Cancer
NCT04719455

Unknown

Adherence Improving Self-Management Strategy (AIMS) in Breast Cancer Patients Using Adjuvant Endocrine Treatment (AET)

Breast Cancer | Breast Neoplasms
NCT00738777

Suspended

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Breast Cancer
NCT03136367

Completed

What Matters Most: Choosing the Right Breast Cancer Surgery for You

Breast Cancer
NCT04659551

Completed

Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients (GIADA)

Breast Cancer
NCT04645849

Unknown

Feasibility Study on the Characterization of the Immune Profile of Young Patients After Treatment for Breast Cancer (C-PiACs)

Breast Cancer
NCT03535961

Completed

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Breast Cancer
NCT01192308

Completed

PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM) (KINETAM)

Breast Cancer
NCT02305628

Completed

An Observational Study of Herceptin SC Safety in Breast Cancer

Breast Cancer
NCT02103387

Completed

Five Sessions Intervention to Facilitate Adaptation to Breast Cancer

Breast Cancer
NCT02366806

Completed

Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer

Breast Cancer
NCT01629615

Completed

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations